29.07.2013 Views

Medicaid Managed Care - U.S. Senate Special Committee on Aging

Medicaid Managed Care - U.S. Senate Special Committee on Aging

Medicaid Managed Care - U.S. Senate Special Committee on Aging

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

638<br />

Broad and explicit state health department involvement at all stages of the 1115 process.<br />

A. Assuring the Integrati<strong>on</strong> of all State Departmental Resources for<br />

Transiti<strong>on</strong> to <str<strong>on</strong>g>Medicaid</str<strong>on</strong>g> <str<strong>on</strong>g>Managed</str<strong>on</strong>g> <str<strong>on</strong>g>Care</str<strong>on</strong>g> in order to ensure greater<br />

commitment <strong>on</strong> the part of state <str<strong>on</strong>g>Medicaid</str<strong>on</strong>g> staff to the c<strong>on</strong>versi<strong>on</strong> to<br />

managed care, staff needs to be fully integrated into a collaborative<br />

process by which planning of the pre-applieati<strong>on</strong> and design phase<br />

takes place. Staff also should be involved during the approval,<br />

implementati<strong>on</strong> and m<strong>on</strong>itoring and evaluati<strong>on</strong> phases, again to<br />

ensure an understanding of the goals to be achieved and a<br />

commitment to facilitating the transiti<strong>on</strong>.<br />

The appropriate state agencies, including public health, should be<br />

invited to provide the necessary resources for adequate technical<br />

assistance to the state <str<strong>on</strong>g>Medicaid</str<strong>on</strong>g> agency to assist in anticipating<br />

potential problem areas.<br />

B. Rec<strong>on</strong>ciling C<strong>on</strong>flicting Policies between State Departmental<br />

Discreti<strong>on</strong>ary Programs and the New <str<strong>on</strong>g>Medicaid</str<strong>on</strong>g> System<br />

Programmatic authority for health care services to vulnerable<br />

populati<strong>on</strong>s (pers<strong>on</strong>s with HIV/AIDS, minority populati<strong>on</strong>s, and<br />

pers<strong>on</strong>s with mental health and substance abusc probles)<br />

historically have been a central missi<strong>on</strong> of PHS agencies, such as<br />

Ryan White CARE Act Title I and 11 funds, Maternal Child Health<br />

Block grants, Mental Health/Substance Abuse Block grants and so<br />

<strong>on</strong>. The restructuring of the <str<strong>on</strong>g>Medicaid</str<strong>on</strong>g> delivery system inherent in<br />

the 1115 waiver program may place manv of these federally<br />

funded programs in jeopardy due to the loss of <str<strong>on</strong>g>Medicaid</str<strong>on</strong>g><br />

reimbursement dollars. Other asras where this may be problematic<br />

are Federally Qualified Health Centers, and mental health and<br />

substance abuse disorders. Due to these potential c<strong>on</strong>flicts and<br />

ramificati<strong>on</strong>s for much needed programs, the State Department of<br />

Health should assess the impact of its waiver proposal <strong>on</strong> their<br />

federally funded programs that may be working at cross purposes<br />

with their existing <str<strong>on</strong>g>Medicaid</str<strong>on</strong>g> program. The state should identify<br />

policy opti<strong>on</strong>s targeted toward specific programs that may need<br />

assistance during crucial transiti<strong>on</strong> periods in to <str<strong>on</strong>g>Medicaid</str<strong>on</strong>g> managed<br />

care, for example providing transiti<strong>on</strong>al financial support to a<br />

program during the phase-in of <str<strong>on</strong>g>Medicaid</str<strong>on</strong>g> managed care.<br />

2. Stakeholder Involvement in the Development and implementati<strong>on</strong> of Waivers.<br />

State <str<strong>on</strong>g>Medicaid</str<strong>on</strong>g> agencies need to involve public health agencies, social service agencies<br />

and other key stakeholders, such as n<strong>on</strong>-governmental organizati<strong>on</strong>s, c<strong>on</strong>sumer groups<br />

and family members, patient advocacy groups, providers, and any other relevant

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!